Impact of blood lead and manganese levels on metabolic dysfunction-associated steatotic liver disease prevalence: insights from NHANES (2017–2020)
Abstract Background The metabolic dysfunction-associated steatotic liver disease (MASLD) paradigm represents a significant departure from the previous nonalcoholic fatty liver disease (NAFLD) framework, offering a non-stigmatizing approach that enhances awareness and accelerates patient understandin...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2025-03-01
|
| Col·lecció: | BMC Gastroenterology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12876-025-03731-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|